Dr. Reggie Gaudino

Dr. Reggie Gaudino

As Vice President for Scientific Operations and Director of Intellectual Property at Steep
Hill, Dr. Gaudino is building the company’s YnsightTM genetic analysis division as a
companion to Steep Hill’s successful chemical profiling and chemical testing business. As
Director of Genetics, Dr. Gaudino has been recognized as a leader in the field of cannabis

He is building a team to produce the highest quality and respected scientific results suitable
for peer review in the field of cannabis research. Steep Hill will bring these scientific
advancements to market for growers, breeders, and ultimately consumers. Dr. Gaudino also
oversees the day-to-day scientific operations of Steep Hill’s laboratories in California, New
Mexico and Washington, to insure they continue to define, lead and exceed industry
standards. In addition, Dr. Gaudino identifies new IP opportunities and protects existing
Steep Hill IP, through aggressive patent and trademark filing and prosecution.

Prior to his role at Steep Hill, Dr. Gaudino served as a published genetic researcher with 18
years of intellectual property experience in writing, prosecuting and managing patents and
patent portfolios in fields as diverse as software and telecom to biotechnology and
molecular genetics. Dr. Gaudino came to Steep Hill from Sequenom, Inc. (NASDAQ: SQNM)
where he served as a Patent Agent. Previously, Dr. Gaudino managed IP based acquisitions
for the Vortice Research Group, and he also has worked at several law firms such as Grant
Anderson LLP, Biotechnology Law Group, Gray Cary Ware & Freidenrich and Lyon & Lyon,
in addition to serving as an advisor and consultant to portfolio investment companies.

Dr. Gaudino received his B.S. in Molecular Biology and Ph.D. in Molecular Genetics from the
State University of New York at Buffalo, and he conducted four years of post-doctoral
research at the Washington University in St. Louis, studying transcriptional regulation of

Close Menu